Background: Psoriasis is a disease with many manifestations for which numerous treatments
are available. Objective: The purpose of this article is to assess whether complete clearance …

The armamentarium of therapies for psoriasis continues to expand with drugs such as
tazarotene, calcipotriene, and acitretin approved in recent years. New forms of old …

Although there is no cure for psoriasis, a variety of treatments are available to reduce the
severity of symptoms and lessen their impact on the patient's quality of life. For patients with …

Psoriasis is a chronic, inflammatory, hyperproliferative skin disease that affects 1–2% of the
general population in the UK and US. Plaque psoriasis is the most common form …

A prospective, randomized, double-blind, placebo-controlled trial was performed to assess
the effect of a potent topical corticosteroid cream used in conjunction with ultraviolet B (UVB) …

Many authors currently advocate 10–20% dosage increments between phototherapy
sessions when treating psoriasis with narrowband ultraviolet B (UVB). However, such …

Psoriasis is one of the more common forms of chronic dermatitis in the world. The latest US‐
wide epidemiological study conducted by the author revealed a prevalence rate of 2.6% of …

An individualized treatment regimen is necessary for each patient with psoriasis because of
the diverse nature of the disease. The manifestation of psoriasis, the severity and extent of …

Psoriasis patients deserve long-term control of their disease with optimal safety. Traditional
agents (methotrexate, cyclosporine, retinoids, and photochemotherapy [PUVS]), although …

Background: Topical therapy providing initial improvement and maintenance of effect after
treatment of the large majority of patients with limited, mild to moderate psoriasis is not …